Mayne Pharma | MYX - Current Liabilities


Mayne Pharma reported AUD313.94M in Current Liabilities for its fiscal semester ending in June of 2024.





Current Liabilities Change Date
Ansell USD 468.9M 53.1M Dec/2025
Avita Medical AUD 62.68M 77K Dec/2025
Cochlear AUD 558.9M 43.4M Dec/2025
CSL USD 4.61B 207M Dec/2025
Healius AUD 804.2M 203.9M Dec/2024
Integral Diagnostics AUD 85.68M 388K Jun/2024
Medical Developments International AUD 5.56M 2.26M Dec/2025
Nanosonics AUD 36.59M 3.2M Dec/2025
Polynovo AUD 22.81M 5.07M Dec/2025
Ramsay Health Care AUD 3.95B 514.2M Dec/2025
ResMed USD 1.35B 103.1M Mar/2026
Sigma Healthcare AUD 1.7B 1.33B Dec/2025
Sonic Healthcare AUD 2.23B 92.84M Dec/2024
Telix Pharmaceuticals AUD 242.34M 10.72M Jun/2026